Your browser doesn't support javascript.
Response to: SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe.
Krasemann, Susanne; Glatzel, Markus; Pless, Ole.
  • Krasemann S; Institute for Neuropathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; Experimental Pathology Core Facility, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. Electronic address: s.krasemann@uke.de.
  • Glatzel M; Institute for Neuropathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Pless O; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Discovery Research Screening Port, 22525 Hamburg, Germany; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), 60596 Frankfurt am Main, Germany. Electronic address: ole.pless@itmp.fraunhofer.de.
Stem Cell Reports ; 17(5): 1014-1015, 2022 05 10.
Article in English | MEDLINE | ID: covidwho-1839323
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon Type I / COVID-19 Limits: Humans Language: English Journal: Stem Cell Reports Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon Type I / COVID-19 Limits: Humans Language: English Journal: Stem Cell Reports Year: 2022 Document Type: Article